Navigation Links
Studies challenge standards to improve treatment outcomes for patients with clotting disorders
Date:12/8/2012

(ATLANTA, December 8, 2012) Studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH) examine current treatment standards for patients with clotting disorders in an effort to improve outcomes. The studies evaluate long-held treatment standards and whether modifications in intensity and duration of therapy may offer equally effective outcomes while reducing toxicities and relapse rates.

Although significant advances have been made in delivering new and improved therapies for clotting disorders, treatment still presents challenges; patients must balance the burden of therapy and risk of treatment-related bleeding with the threat of potentially life-threatening clotting. The studies presented today examine how simple strategies in the treatment of polycythemia vera (PV) and venous thromboembolism (VTE) may be safe and help produce more effective results in patients with these disorders.

"It is important to constantly evaluate and challenge standard treatment protocols to ensure that we are utililizing the best possible strategies to treat patients with these serious disorders," said Agnes Y. Lee, MD, moderator of the press conference and Medical Director of the Thrombosis Program and Associate Professor of Medicine at the University of British Columbia and Vancouver Coastal Health in Canada. "Additionally, as we are seeing an increasing number of patients who require ongoing, long-term treatment, it is important to find new ways to improve efficacy and lower the risks of potentially life-threatening complications that accompany these aggressive therapies."

This press conference will take place on Saturday, December 8, 2012, at 2:00 p.m. EST.

A Large-Scale Trial Testing the Intensity of Cytoreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera (CYTO-PV trial) [Abs
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
2. John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
3. Benefit6 Whole Body Protection, a New Product by I Do Strive LLC, Provides Increased Energy Production According to Recent Studies
4. Sharp spike in computer-related injuries predicted for medical workers, find studies
5. Analysis of conflicting fish oil studies finds that omega-3 fatty acids still matter
6. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
7. New studies show effects of mammography guideline changes
8. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
9. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
10. Cancer Drug Reduced Relapses in MS Patients: Studies
11. University of Houston India Studies Program presents Circuits of Empire: India as Metropole
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... , ... At the presentation of the 2015 Annual Meeting of the American Academy of ... the Journal of Arthroplasty pertaining to how soon after undergoing hip replacement surgery (THR) ... study confirm what Santa Rosa Orthopaedics (SRO) surgeon Nathan Ehmer D.O . ...
(Date:7/30/2015)... ... July 30, 2015 , ... Case Mason ( http://www.casemason.com ), ... brands, recently completed a consolidation of all of its production capabilities to a ... of two separate locations situated 11 miles apart. , The advantages of consolidating ...
(Date:7/30/2015)... ... , ... PeopleKeys, a company with over 30 years of experience in behavioral ... webinar, the newest installment in their popular DISC for the Real World series, will ... Trainer webinar is intended for people interested in training others to use DISC behavioral ...
(Date:7/30/2015)... ... ... Addictions Training Institute has announced the launch of a fully ... Abuse Counselors. , "We are thrilled to be launching Addictions Training Institute,” said Ron ... and Drug Counselors nationwide. We are excited to be helping fill this need ...
(Date:7/29/2015)... Francisco, California (PRWEB) , ... July 30, 2015 , ... ... Jimi Hendrix Dorton Arena Raleigh North Carolina concert posters. The same poster art was ... were printed by Globe Poster based in Baltimore and are classic boxing style concert ...
Breaking Medicine News(10 mins):Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 3Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 2Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 3Health News:PeopleKeys to Air “Managing Stress: Train the Trainer” DISC Webinar 2Health News:Addictions Training Institute Announces New Online Certificate Program for Alcohol and Drug Counselors 2
... use of oral chemotherapy in US cancer centres need to ... ,Common malignancies can be treated with oral chemotherapy ... and internationally. ,Researchers from Boston set out ... centres for the provision of oral chemotherapy. Forty-two centres took ...
... rest on the couch to recover before returning to sports, ... at least not yet. // ,One Ohio State University ... devices for the heart will be put to use temporarily ... Right now, such heart pumps, known commonly as ventricular assist ...
... Vanderbilt Kennedy Center for Research on Human Development has ... and behavioral //and neurological problems in the child. ... Gregg Stanwood, Ph.D., and Pat Levitt, Ph.D., have elaborated ... rabbits, which caused a prolonged displacement of dopamine receptors ...
... the onset of type 1 diabetes in mice prone ... receptor on the surface of immune T-cells. // This ... journal Diabetes, have significant implications for the prevention of ... Americans have type 1 diabetes, an autoimmune disorder in ...
... warns a senior doctor in this week’s BMJ. ... causes of delayed discharge are associated with inadequate care ... medication errors. ,This crisis is the result ... care, and poor leadership, and it is directly harming ...
... Canisius College is giving children with Asperger’s Disorder (AD) ... ,Asperger’s Disorder is a high functioning form of ... inability to recognize emotions in others and narrow, often ... Spectrum Disorders Research Consortium, Canisius professors Robert E. Nida, ...
Cached Medicine News:Health News:Pumps Someday May Allow Patients to Recover Their Own Hearts 2Health News:Pumps Someday May Allow Patients to Recover Their Own Hearts 3Health News:Cocaine During Pregnancy can Cause Behavioral and Neurological Problems in the Child 2Health News:Cocaine During Pregnancy can Cause Behavioral and Neurological Problems in the Child 3Health News:Antibody Therapy Prevents Type 1 Diabetes 2Health News:Connections Program Offers Hope to Children With Asperger's Disorder 2Health News:Connections Program Offers Hope to Children With Asperger's Disorder 3
(Date:7/29/2015)... July 29, 2015 Sangamo BioSciences, Inc. (NASDAQ: ... release its second quarter 2015 financial results after the ... release will be followed by a conference call at ... public via telephone and webcast. During the conference call, ... discuss other business matters. The conference call ...
(Date:7/29/2015)... 29, 2015 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... up to $21.5 million through two financing agreements. The ... ) ("Hercules"), for a term loan of up to ... Growth Fund ("Discover"), for the sale to Discover of ... Stock") for up to $12 million in gross proceeds ...
(Date:7/29/2015)... Washington , 29 luglio 2015 ... ha scoperto che l,ingestione quotidiana del probiotico ... intestinale umano e modifica la produzione intestinale di ... studio riguardava la somministrazione quotidiana di ceppo di ... SD-5865) in compresse utilizzando il sistema di somministrazione ...
Breaking Medicine Technology:Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 6Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 7È stato clinicamente dimostrato che il probiotico L. reuteri di Nutraceutix regola il metabolismo insulinico intestinale 2
... Dystrophy Association announced today that SMT C1100, an experimental ... received approval from regulatory agencies in the United Kingdom ... healthy human volunteers. (Logo: http://photos.prnewswire.com/prnh/20120424/DC93207LOGO ) ... of a muscle protein utrophin that can potentially compensate ...
... Argos Therapeutics Inc. today announced that it has ... the commencement of its Phase 3 ADAPT study in ... in mid-2012. The financing was led by Forbion Capital ... Capital, Intersouth Partners, Caisse de depot et placement du ...
Cached Medicine Technology:SMT C1100 For Duchenne Muscular Dystrophy Moves To Human Testing 2SMT C1100 For Duchenne Muscular Dystrophy Moves To Human Testing 3Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012 2Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012 3
... a vital dye, used in matured cataract ... fibrous tissue enables the surgeon to see ... preparation of trypan blue combined with sodium ... tolerated following intraocular injection into the anterior ...
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Refkeratometer...
Portable, easy to align, automatic measurement, automatic fogging. Accurate and dependable readings. Infrared printer communication. Rechargeable battery. Integrates with the TRS-2100 and EPIC-2100 r...
Medicine Products: